0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peptide Modification Service Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-15U16830
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Peptide Modification Service Market Research Report 2024
BUY CHAPTERS

Global Peptide Modification Service Market Research Report 2025

Code: QYRE-Auto-15U16830
Report
September 2025
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Peptide Modification Service Market

The global market for Peptide Modification Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Peptide Modification Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Peptide Modification Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Peptide Modification Service in Commercial is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Peptide Modification Service include GenScript, Biosynth, Bio-Synthesis, Thermo Fisher Scientific, Syd Labs, JPT, LifeTein, Creative Peptides, Elabscience, Genosphere Biotechnologies, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Peptide Modification Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Modification Service.
The Peptide Modification Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide Modification Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Modification Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Peptide Modification Service Market Report

Report Metric Details
Report Name Peptide Modification Service Market
Segment by Type
  • N-Terminal Modifications
  • C-Terminal Modifications
  • Fluorescence Dye Labeling
  • Phosphorylation
  • Others
Segment by Application
  • Commercial
  • Academic Research
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GenScript, Biosynth, Bio-Synthesis, Thermo Fisher Scientific, Syd Labs, JPT, LifeTein, Creative Peptides, Elabscience, Genosphere Biotechnologies, ProSci, Giotto Biotech, SB-PEPTIDE, Biomatik, allele life sciences, Synpeptide, Omizzur, KMD Bioscience, Leadgene Biomedical, KenPeptide, CASLO, TGpeptide, Boston Cellron, Bio Basic
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Peptide Modification Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Peptide Modification Service Market report?

Ans: The main players in the Peptide Modification Service Market are GenScript, Biosynth, Bio-Synthesis, Thermo Fisher Scientific, Syd Labs, JPT, LifeTein, Creative Peptides, Elabscience, Genosphere Biotechnologies, ProSci, Giotto Biotech, SB-PEPTIDE, Biomatik, allele life sciences, Synpeptide, Omizzur, KMD Bioscience, Leadgene Biomedical, KenPeptide, CASLO, TGpeptide, Boston Cellron, Bio Basic

What are the Application segmentation covered in the Peptide Modification Service Market report?

Ans: The Applications covered in the Peptide Modification Service Market report are Commercial, Academic Research

What are the Type segmentation covered in the Peptide Modification Service Market report?

Ans: The Types covered in the Peptide Modification Service Market report are N-Terminal Modifications, C-Terminal Modifications, Fluorescence Dye Labeling, Phosphorylation, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Modification Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 N-Terminal Modifications
1.2.3 C-Terminal Modifications
1.2.4 Fluorescence Dye Labeling
1.2.5 Phosphorylation
1.2.6 Others
1.3 Market by Application
1.3.1 Global Peptide Modification Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Commercial
1.3.3 Academic Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Modification Service Market Perspective (2020-2031)
2.2 Global Peptide Modification Service Growth Trends by Region
2.2.1 Global Peptide Modification Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Peptide Modification Service Historic Market Size by Region (2020-2025)
2.2.3 Peptide Modification Service Forecasted Market Size by Region (2026-2031)
2.3 Peptide Modification Service Market Dynamics
2.3.1 Peptide Modification Service Industry Trends
2.3.2 Peptide Modification Service Market Drivers
2.3.3 Peptide Modification Service Market Challenges
2.3.4 Peptide Modification Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide Modification Service Players by Revenue
3.1.1 Global Top Peptide Modification Service Players by Revenue (2020-2025)
3.1.2 Global Peptide Modification Service Revenue Market Share by Players (2020-2025)
3.2 Global Peptide Modification Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Peptide Modification Service Revenue
3.4 Global Peptide Modification Service Market Concentration Ratio
3.4.1 Global Peptide Modification Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Modification Service Revenue in 2024
3.5 Global Key Players of Peptide Modification Service Head office and Area Served
3.6 Global Key Players of Peptide Modification Service, Product and Application
3.7 Global Key Players of Peptide Modification Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Modification Service Breakdown Data by Type
4.1 Global Peptide Modification Service Historic Market Size by Type (2020-2025)
4.2 Global Peptide Modification Service Forecasted Market Size by Type (2026-2031)
5 Peptide Modification Service Breakdown Data by Application
5.1 Global Peptide Modification Service Historic Market Size by Application (2020-2025)
5.2 Global Peptide Modification Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Peptide Modification Service Market Size (2020-2031)
6.2 North America Peptide Modification Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Peptide Modification Service Market Size by Country (2020-2025)
6.4 North America Peptide Modification Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide Modification Service Market Size (2020-2031)
7.2 Europe Peptide Modification Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Peptide Modification Service Market Size by Country (2020-2025)
7.4 Europe Peptide Modification Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide Modification Service Market Size (2020-2031)
8.2 Asia-Pacific Peptide Modification Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Peptide Modification Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Peptide Modification Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide Modification Service Market Size (2020-2031)
9.2 Latin America Peptide Modification Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Peptide Modification Service Market Size by Country (2020-2025)
9.4 Latin America Peptide Modification Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide Modification Service Market Size (2020-2031)
10.2 Middle East & Africa Peptide Modification Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Peptide Modification Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Peptide Modification Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GenScript
11.1.1 GenScript Company Details
11.1.2 GenScript Business Overview
11.1.3 GenScript Peptide Modification Service Introduction
11.1.4 GenScript Revenue in Peptide Modification Service Business (2020-2025)
11.1.5 GenScript Recent Development
11.2 Biosynth
11.2.1 Biosynth Company Details
11.2.2 Biosynth Business Overview
11.2.3 Biosynth Peptide Modification Service Introduction
11.2.4 Biosynth Revenue in Peptide Modification Service Business (2020-2025)
11.2.5 Biosynth Recent Development
11.3 Bio-Synthesis
11.3.1 Bio-Synthesis Company Details
11.3.2 Bio-Synthesis Business Overview
11.3.3 Bio-Synthesis Peptide Modification Service Introduction
11.3.4 Bio-Synthesis Revenue in Peptide Modification Service Business (2020-2025)
11.3.5 Bio-Synthesis Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Peptide Modification Service Introduction
11.4.4 Thermo Fisher Scientific Revenue in Peptide Modification Service Business (2020-2025)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Syd Labs
11.5.1 Syd Labs Company Details
11.5.2 Syd Labs Business Overview
11.5.3 Syd Labs Peptide Modification Service Introduction
11.5.4 Syd Labs Revenue in Peptide Modification Service Business (2020-2025)
11.5.5 Syd Labs Recent Development
11.6 JPT
11.6.1 JPT Company Details
11.6.2 JPT Business Overview
11.6.3 JPT Peptide Modification Service Introduction
11.6.4 JPT Revenue in Peptide Modification Service Business (2020-2025)
11.6.5 JPT Recent Development
11.7 LifeTein
11.7.1 LifeTein Company Details
11.7.2 LifeTein Business Overview
11.7.3 LifeTein Peptide Modification Service Introduction
11.7.4 LifeTein Revenue in Peptide Modification Service Business (2020-2025)
11.7.5 LifeTein Recent Development
11.8 Creative Peptides
11.8.1 Creative Peptides Company Details
11.8.2 Creative Peptides Business Overview
11.8.3 Creative Peptides Peptide Modification Service Introduction
11.8.4 Creative Peptides Revenue in Peptide Modification Service Business (2020-2025)
11.8.5 Creative Peptides Recent Development
11.9 Elabscience
11.9.1 Elabscience Company Details
11.9.2 Elabscience Business Overview
11.9.3 Elabscience Peptide Modification Service Introduction
11.9.4 Elabscience Revenue in Peptide Modification Service Business (2020-2025)
11.9.5 Elabscience Recent Development
11.10 Genosphere Biotechnologies
11.10.1 Genosphere Biotechnologies Company Details
11.10.2 Genosphere Biotechnologies Business Overview
11.10.3 Genosphere Biotechnologies Peptide Modification Service Introduction
11.10.4 Genosphere Biotechnologies Revenue in Peptide Modification Service Business (2020-2025)
11.10.5 Genosphere Biotechnologies Recent Development
11.11 ProSci
11.11.1 ProSci Company Details
11.11.2 ProSci Business Overview
11.11.3 ProSci Peptide Modification Service Introduction
11.11.4 ProSci Revenue in Peptide Modification Service Business (2020-2025)
11.11.5 ProSci Recent Development
11.12 Giotto Biotech
11.12.1 Giotto Biotech Company Details
11.12.2 Giotto Biotech Business Overview
11.12.3 Giotto Biotech Peptide Modification Service Introduction
11.12.4 Giotto Biotech Revenue in Peptide Modification Service Business (2020-2025)
11.12.5 Giotto Biotech Recent Development
11.13 SB-PEPTIDE
11.13.1 SB-PEPTIDE Company Details
11.13.2 SB-PEPTIDE Business Overview
11.13.3 SB-PEPTIDE Peptide Modification Service Introduction
11.13.4 SB-PEPTIDE Revenue in Peptide Modification Service Business (2020-2025)
11.13.5 SB-PEPTIDE Recent Development
11.14 Biomatik
11.14.1 Biomatik Company Details
11.14.2 Biomatik Business Overview
11.14.3 Biomatik Peptide Modification Service Introduction
11.14.4 Biomatik Revenue in Peptide Modification Service Business (2020-2025)
11.14.5 Biomatik Recent Development
11.15 allele life sciences
11.15.1 allele life sciences Company Details
11.15.2 allele life sciences Business Overview
11.15.3 allele life sciences Peptide Modification Service Introduction
11.15.4 allele life sciences Revenue in Peptide Modification Service Business (2020-2025)
11.15.5 allele life sciences Recent Development
11.16 Synpeptide
11.16.1 Synpeptide Company Details
11.16.2 Synpeptide Business Overview
11.16.3 Synpeptide Peptide Modification Service Introduction
11.16.4 Synpeptide Revenue in Peptide Modification Service Business (2020-2025)
11.16.5 Synpeptide Recent Development
11.17 Omizzur
11.17.1 Omizzur Company Details
11.17.2 Omizzur Business Overview
11.17.3 Omizzur Peptide Modification Service Introduction
11.17.4 Omizzur Revenue in Peptide Modification Service Business (2020-2025)
11.17.5 Omizzur Recent Development
11.18 KMD Bioscience
11.18.1 KMD Bioscience Company Details
11.18.2 KMD Bioscience Business Overview
11.18.3 KMD Bioscience Peptide Modification Service Introduction
11.18.4 KMD Bioscience Revenue in Peptide Modification Service Business (2020-2025)
11.18.5 KMD Bioscience Recent Development
11.19 Leadgene Biomedical
11.19.1 Leadgene Biomedical Company Details
11.19.2 Leadgene Biomedical Business Overview
11.19.3 Leadgene Biomedical Peptide Modification Service Introduction
11.19.4 Leadgene Biomedical Revenue in Peptide Modification Service Business (2020-2025)
11.19.5 Leadgene Biomedical Recent Development
11.20 KenPeptide
11.20.1 KenPeptide Company Details
11.20.2 KenPeptide Business Overview
11.20.3 KenPeptide Peptide Modification Service Introduction
11.20.4 KenPeptide Revenue in Peptide Modification Service Business (2020-2025)
11.20.5 KenPeptide Recent Development
11.21 CASLO
11.21.1 CASLO Company Details
11.21.2 CASLO Business Overview
11.21.3 CASLO Peptide Modification Service Introduction
11.21.4 CASLO Revenue in Peptide Modification Service Business (2020-2025)
11.21.5 CASLO Recent Development
11.22 TGpeptide
11.22.1 TGpeptide Company Details
11.22.2 TGpeptide Business Overview
11.22.3 TGpeptide Peptide Modification Service Introduction
11.22.4 TGpeptide Revenue in Peptide Modification Service Business (2020-2025)
11.22.5 TGpeptide Recent Development
11.23 Boston Cellron
11.23.1 Boston Cellron Company Details
11.23.2 Boston Cellron Business Overview
11.23.3 Boston Cellron Peptide Modification Service Introduction
11.23.4 Boston Cellron Revenue in Peptide Modification Service Business (2020-2025)
11.23.5 Boston Cellron Recent Development
11.24 Bio Basic
11.24.1 Bio Basic Company Details
11.24.2 Bio Basic Business Overview
11.24.3 Bio Basic Peptide Modification Service Introduction
11.24.4 Bio Basic Revenue in Peptide Modification Service Business (2020-2025)
11.24.5 Bio Basic Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Peptide Modification Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of N-Terminal Modifications
 Table 3. Key Players of C-Terminal Modifications
 Table 4. Key Players of Fluorescence Dye Labeling
 Table 5. Key Players of Phosphorylation
 Table 6. Key Players of Others
 Table 7. Global Peptide Modification Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Peptide Modification Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Peptide Modification Service Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Peptide Modification Service Market Share by Region (2020-2025)
 Table 11. Global Peptide Modification Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Peptide Modification Service Market Share by Region (2026-2031)
 Table 13. Peptide Modification Service Market Trends
 Table 14. Peptide Modification Service Market Drivers
 Table 15. Peptide Modification Service Market Challenges
 Table 16. Peptide Modification Service Market Restraints
 Table 17. Global Peptide Modification Service Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Peptide Modification Service Market Share by Players (2020-2025)
 Table 19. Global Top Peptide Modification Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Modification Service as of 2024)
 Table 20. Ranking of Global Top Peptide Modification Service Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Peptide Modification Service Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Peptide Modification Service, Headquarters and Area Served
 Table 23. Global Key Players of Peptide Modification Service, Product and Application
 Table 24. Global Key Players of Peptide Modification Service, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Peptide Modification Service Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Peptide Modification Service Revenue Market Share by Type (2020-2025)
 Table 28. Global Peptide Modification Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Peptide Modification Service Revenue Market Share by Type (2026-2031)
 Table 30. Global Peptide Modification Service Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Peptide Modification Service Revenue Market Share by Application (2020-2025)
 Table 32. Global Peptide Modification Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Peptide Modification Service Revenue Market Share by Application (2026-2031)
 Table 34. North America Peptide Modification Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Peptide Modification Service Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Peptide Modification Service Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Peptide Modification Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Peptide Modification Service Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Peptide Modification Service Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Peptide Modification Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Peptide Modification Service Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Peptide Modification Service Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Peptide Modification Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Peptide Modification Service Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Peptide Modification Service Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Peptide Modification Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Peptide Modification Service Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Peptide Modification Service Market Size by Country (2026-2031) & (US$ Million)
 Table 49. GenScript Company Details
 Table 50. GenScript Business Overview
 Table 51. GenScript Peptide Modification Service Product
 Table 52. GenScript Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 53. GenScript Recent Development
 Table 54. Biosynth Company Details
 Table 55. Biosynth Business Overview
 Table 56. Biosynth Peptide Modification Service Product
 Table 57. Biosynth Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 58. Biosynth Recent Development
 Table 59. Bio-Synthesis Company Details
 Table 60. Bio-Synthesis Business Overview
 Table 61. Bio-Synthesis Peptide Modification Service Product
 Table 62. Bio-Synthesis Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 63. Bio-Synthesis Recent Development
 Table 64. Thermo Fisher Scientific Company Details
 Table 65. Thermo Fisher Scientific Business Overview
 Table 66. Thermo Fisher Scientific Peptide Modification Service Product
 Table 67. Thermo Fisher Scientific Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 68. Thermo Fisher Scientific Recent Development
 Table 69. Syd Labs Company Details
 Table 70. Syd Labs Business Overview
 Table 71. Syd Labs Peptide Modification Service Product
 Table 72. Syd Labs Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 73. Syd Labs Recent Development
 Table 74. JPT Company Details
 Table 75. JPT Business Overview
 Table 76. JPT Peptide Modification Service Product
 Table 77. JPT Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 78. JPT Recent Development
 Table 79. LifeTein Company Details
 Table 80. LifeTein Business Overview
 Table 81. LifeTein Peptide Modification Service Product
 Table 82. LifeTein Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 83. LifeTein Recent Development
 Table 84. Creative Peptides Company Details
 Table 85. Creative Peptides Business Overview
 Table 86. Creative Peptides Peptide Modification Service Product
 Table 87. Creative Peptides Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 88. Creative Peptides Recent Development
 Table 89. Elabscience Company Details
 Table 90. Elabscience Business Overview
 Table 91. Elabscience Peptide Modification Service Product
 Table 92. Elabscience Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 93. Elabscience Recent Development
 Table 94. Genosphere Biotechnologies Company Details
 Table 95. Genosphere Biotechnologies Business Overview
 Table 96. Genosphere Biotechnologies Peptide Modification Service Product
 Table 97. Genosphere Biotechnologies Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 98. Genosphere Biotechnologies Recent Development
 Table 99. ProSci Company Details
 Table 100. ProSci Business Overview
 Table 101. ProSci Peptide Modification Service Product
 Table 102. ProSci Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 103. ProSci Recent Development
 Table 104. Giotto Biotech Company Details
 Table 105. Giotto Biotech Business Overview
 Table 106. Giotto Biotech Peptide Modification Service Product
 Table 107. Giotto Biotech Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 108. Giotto Biotech Recent Development
 Table 109. SB-PEPTIDE Company Details
 Table 110. SB-PEPTIDE Business Overview
 Table 111. SB-PEPTIDE Peptide Modification Service Product
 Table 112. SB-PEPTIDE Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 113. SB-PEPTIDE Recent Development
 Table 114. Biomatik Company Details
 Table 115. Biomatik Business Overview
 Table 116. Biomatik Peptide Modification Service Product
 Table 117. Biomatik Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 118. Biomatik Recent Development
 Table 119. allele life sciences Company Details
 Table 120. allele life sciences Business Overview
 Table 121. allele life sciences Peptide Modification Service Product
 Table 122. allele life sciences Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 123. allele life sciences Recent Development
 Table 124. Synpeptide Company Details
 Table 125. Synpeptide Business Overview
 Table 126. Synpeptide Peptide Modification Service Product
 Table 127. Synpeptide Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 128. Synpeptide Recent Development
 Table 129. Omizzur Company Details
 Table 130. Omizzur Business Overview
 Table 131. Omizzur Peptide Modification Service Product
 Table 132. Omizzur Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 133. Omizzur Recent Development
 Table 134. KMD Bioscience Company Details
 Table 135. KMD Bioscience Business Overview
 Table 136. KMD Bioscience Peptide Modification Service Product
 Table 137. KMD Bioscience Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 138. KMD Bioscience Recent Development
 Table 139. Leadgene Biomedical Company Details
 Table 140. Leadgene Biomedical Business Overview
 Table 141. Leadgene Biomedical Peptide Modification Service Product
 Table 142. Leadgene Biomedical Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 143. Leadgene Biomedical Recent Development
 Table 144. KenPeptide Company Details
 Table 145. KenPeptide Business Overview
 Table 146. KenPeptide Peptide Modification Service Product
 Table 147. KenPeptide Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 148. KenPeptide Recent Development
 Table 149. CASLO Company Details
 Table 150. CASLO Business Overview
 Table 151. CASLO Peptide Modification Service Product
 Table 152. CASLO Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 153. CASLO Recent Development
 Table 154. TGpeptide Company Details
 Table 155. TGpeptide Business Overview
 Table 156. TGpeptide Peptide Modification Service Product
 Table 157. TGpeptide Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 158. TGpeptide Recent Development
 Table 159. Boston Cellron Company Details
 Table 160. Boston Cellron Business Overview
 Table 161. Boston Cellron Peptide Modification Service Product
 Table 162. Boston Cellron Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 163. Boston Cellron Recent Development
 Table 164. Bio Basic Company Details
 Table 165. Bio Basic Business Overview
 Table 166. Bio Basic Peptide Modification Service Product
 Table 167. Bio Basic Revenue in Peptide Modification Service Business (2020-2025) & (US$ Million)
 Table 168. Bio Basic Recent Development
 Table 169. Research Programs/Design for This Report
 Table 170. Key Data Information from Secondary Sources
 Table 171. Key Data Information from Primary Sources
 Table 172. Authors List of This Report


List of Figures
 Figure 1. Peptide Modification Service Picture
 Figure 2. Global Peptide Modification Service Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Peptide Modification Service Market Share by Type: 2024 VS 2031
 Figure 4. N-Terminal Modifications Features
 Figure 5. C-Terminal Modifications Features
 Figure 6. Fluorescence Dye Labeling Features
 Figure 7. Phosphorylation Features
 Figure 8. Others Features
 Figure 9. Global Peptide Modification Service Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Peptide Modification Service Market Share by Application: 2024 VS 2031
 Figure 11. Commercial Case Studies
 Figure 12. Academic Research Case Studies
 Figure 13. Peptide Modification Service Report Years Considered
 Figure 14. Global Peptide Modification Service Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Peptide Modification Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Peptide Modification Service Market Share by Region: 2024 VS 2031
 Figure 17. Global Peptide Modification Service Market Share by Players in 2024
 Figure 18. Global Top Peptide Modification Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Modification Service as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Peptide Modification Service Revenue in 2024
 Figure 20. North America Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Peptide Modification Service Market Share by Country (2020-2031)
 Figure 22. United States Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Peptide Modification Service Market Share by Country (2020-2031)
 Figure 26. Germany Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Peptide Modification Service Market Share by Region (2020-2031)
 Figure 34. China Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Peptide Modification Service Market Share by Country (2020-2031)
 Figure 42. Mexico Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Peptide Modification Service Market Share by Country (2020-2031)
 Figure 46. Turkey Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Peptide Modification Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. GenScript Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 50. Biosynth Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 51. Bio-Synthesis Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 53. Syd Labs Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 54. JPT Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 55. LifeTein Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 56. Creative Peptides Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 57. Elabscience Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 58. Genosphere Biotechnologies Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 59. ProSci Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 60. Giotto Biotech Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 61. SB-PEPTIDE Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 62. Biomatik Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 63. allele life sciences Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 64. Synpeptide Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 65. Omizzur Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 66. KMD Bioscience Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 67. Leadgene Biomedical Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 68. KenPeptide Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 69. CASLO Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 70. TGpeptide Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 71. Boston Cellron Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 72. Bio Basic Revenue Growth Rate in Peptide Modification Service Business (2020-2025)
 Figure 73. Bottom-up and Top-down Approaches for This Report
 Figure 74. Data Triangulation
 Figure 75. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc